Movetis Files RESOLOR(R) With EMEA for the Indication of Chronic Constipation

29.05.2008 18:40:11
Movetis NV: Turnhout, Belgium (ots/PRNewswire) - Movetis today announced that the European Medicines Agency (EMeA) has accepted the Marketing Authorization Application (MAA) submission for RESOLOR(R) (prucalopride) as a treatment for chronic constipation in ...

Lesen Sie hier weiter... |  Drucken |  PDF

Ähnliche Artikel




Neue Daten bestätigen beständige Wirksamkeit und unbedenkliches ...

Support Safety and Efficacy of RESOLOR(R) for Treatment of Chronic Constipation.Movetis Files RESOLOR(R) With EMEA for the Indication of Chronic Constipation


Presseportal: Movetis NV - Neue Daten bestätigen beständige Wirksamkeit ...

36 Movetis Files RESOLOR(R) With EMEA for the Indication of Chronic Constipation Effectiveness and Safety of RESOLOR(R) for Patients With Chronic Constipation


ots.at: das APA-OTS-Portal für multimediale Presseaussendungen

Movetis Files RESOLOR(R) With EMEA for the Indication of Chronic Constipation and Safety of RESOLOR(R) for Patients With Chronic.Constipation


Presseportal.de - Movetis NV

Movetis Files RESOLOR(R) With EMEA for the Indication of Chronic Constipation Effectiveness and Safety of RESOLOR(R) for Patients With Chronic Constipation


Movetis Files RESOLOR(R) With EMEA for the Indication of Chronic ...

Movetis Files RESOLOR(R) With EMEA for the Indication of Chronic Constipation